Open innovation

Our client, an American pharmaceutical group, requested the support of our team to define their open innovation strategy in Europe in order to facilitate their collaboration with European start-ups and researchers.

After having studied the possible collaboration opportunities envisaged by our client (mainly focused on the search for new therapies and R&D techniques), our team carried out an initial mapping of the European hot spots and clusters in the biotech field. In a second step, we carried out a benchmark of the most innovative open innovation approaches implemented in Europe by other players, in healthcare and in other sectors.

Based on the information gathered during our investigations, we organized a workshop with our client’s team in order to co-construct together the best open innovation strategy to implement and define the main steps for its operational deployment.

We supported the R&D team of a leading player in the food industry in optimizing its innovation process to accelerate the marketing of its products. Our client had an innovation process very rich in ideas but internally focused and not very open to an external ecosystem.

This constraint generated many limitations, including slow idea characterization and feasibility checks. By conducting a benchmark of existing open innovation practices in the industry and leading a series of workshops with our client’s teams, we identified and implemented actions to use external partners at various stages of the innovation process in order to accelerate the different stages and thus the marketing of product innovations.

We carried out a benchmark of open innovation practices and approaches in the industry in order to define the model for the future accelerator of a public institution.

Our team analyzed the open innovation practices of the most innovative industry players (Lego, IBM, P&G, Apple and Starbucks) and explored their strategies, approaches, methods, resources, partners in their ecosystems and business models.

The results of our study have inspired our client and facilitated the decisions to be made regarding the model of its future accelerator.

We carried out a benchmark of open innovation practices and approaches in the industry in order to define the model of the future accelerator of a public institution.

To do so, our team analyzed the open innovation practices of the most innovative industry players in this area (Lego, IBM, P&G, Apple and Starbucks) and explored their strategies, approaches, methods, resources, partners in their ecosystems and business models.

The results of our study have been used in a workshop with our client in order to inspire teams and facilitate the decisions to be maderegarding the model of their future accelerator.

Our team assisted a pharmaceutical player who found that their innovation process was not enough agile and open towards the external world.

We first exchanged with our client’s teams to get a detailed understanding of what was working well and to identify the malfunctions of the initial process.

Then, we identified inspiring cases from industries outside healthcare but facing the same issues and we defined the guiding principles of the new process to be implemented. With this material, we organized a “Sprint” bringing together about twenty representatives from the various departments and functions involved in innovation, in order to co-build the new model following the precepts of Design Thinking.

Ultimately, this work enabled us to co-construct with our client’s teams their new innovation process, more focused, more agile and open to partners, allowing more disruption and empowerment of the teams!

Our customer, a French dermo-cosmetic group, was looking for support in defining its open innovation roadmap in France, in order to generate innovative ideas for their R&D.

Firstly, we defined with our customer the strategic imperatives of the company in terms of products R&D and their specific needs for open innovation. Secondly, we collected both internal and external stakeholders’ vision in terms of relevant innovation methods for the company. Thirdly, we benchmarked the most innovative open innovation approaches implemented in Europe by other players in relevant sectors for the client.

Based on the information gathered during our investigations, we organized a one-day workshop with our client to co-build the best open innovation method to implement and define the operational roadmap for them.

Our client, a French medical device company, considered bringing innovative products via open innovation as one of the main pillars of its R&D strategy. To do so, our client needed to rely on partnerships with both public and private institutions.

We supported our client to identify relevant partners for open innovation. Firstly, we detected the existing best practices internally within the existing similar partnerships. Secondly, we identified top academic players (hospital research teams) with capabilities in relevant therapeutic areas and digital technologies required by the customer. Thirdly, we characterized these players according to scientific criteria and their willingness / motivation to collaborate with our customer.

To help our client select the most pertinent partners, we defined the selection criteria and ranked the players accordingly. At the end, we recommended our customer the TOP 3 players for further direct discussion.